Second-line drug therapy for osteoarthritis
dc.contributor.author | Brandt, Kenneth D. | |
dc.contributor.department | Medicine, School of Medicine | en_US |
dc.date.accessioned | 2019-07-17T17:45:37Z | |
dc.date.available | 2019-07-17T17:45:37Z | |
dc.date.issued | 2001-03 | |
dc.identifier.citation | Brandt K. D. (2001). Second-line drug therapy for osteoarthritis. Clinical medicine (London, England), 1(2), 110–114. doi:10.7861/clinmedicine.1-2-110 | en_US |
dc.identifier.uri | https://hdl.handle.net/1805/19894 | |
dc.language.iso | en_US | en_US |
dc.publisher | Royal College of Physicians | en_US |
dc.relation.isversionof | 10.7861/clinmedicine.1-2-110 | en_US |
dc.relation.journal | Clinical medicine | en_US |
dc.rights | Publisher Policy | en_US |
dc.source | PMC | en_US |
dc.subject | Anti-inflammatory agents -- non-steroidal | en_US |
dc.subject | Antirheumatic agents | en_US |
dc.subject | Metalloendopeptidases | en_US |
dc.subject | Osteoarthritis | en_US |
dc.title | Second-line drug therapy for osteoarthritis | en_US |
dc.type | Article | en_US |